Commercialization
Combined entity creates strong foundation for leading Canadian immuno-oncology company TORONTO, ON (January 28, 2016) – FACIT has announced that Trillium Therapeutics Inc. (NASDAQ:TRIL, TSX:TR; “Trillium”) has acquired all of the outstanding shares of privately-held…
Article·